News

Ludwig Burger, John Revill, John Miller FRANKFURT/ZURICH (Reuters) - GlaxoSmithKline (GSK.L) is buying Novartis (NOVN.S) out of their consumer healthcare joint venture for $13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches. GSK’s biggest move since Em...

Work will begin this year on a €60 million development at Trinity College Dublin that will provide 1,800 additional places for students taking courses in science, technology engineering and mathematics (Stem) subjects. The development is being supported by a €25 million donation from Glen Dimplex Group founder Dr Martin Naughton and his wife, Ca...

Up to 25,000 additional pharmaceutical manufacturing jobs could be created in Europe by 2025 with the Republic of Ireland in a strong position to gain a significant number of the new roles, according to one generic drugmaker. Mylan, which employs 1,600 people across four sites in Dublin and Galway, said the additional jobs will only come about i...

A Cork-based biotechnology company has secured €2 million in funding to develop a product to identify whether women could develop preeclampsia. Metabolomic Diagnostics was awarded the funding from the European Union under its Horizon 2020 project, which received a total of 1280 applications. The €2 million will be used to commercialise the compa...

Pharma giant seeks planning for Swords plant Biotech facility to employ 350 on repurposed and expanded Dublin site Thu, Apr 19, 2018, 05:00 Artist’s impression of new MSD site at Swords expanded to 43,000sq m from previous 31,000sq m plant. MSD has submitted planning permission for the construction of its major new biotech plant in Swords. The c...

Brexit prompts US pharma business to invest in Louth and Meath PCI plans to create up to 130 new jobs over five years PCI’s customers were seeking a response to Brexit from the company. Photograph: iStock Elaine Keogh Wed, Apr 25, 2018, 15:22 A global pharma outsourcing company that plans to create up to 130 new jobs in Louth and Meath says Brex...

Parkinson’s disease may start in the gut and travel to the brain It seems the nerve damage behind Parkinson's starts in the stomach or colon before spreading to brain cells - but we don't know what's causing it By Clare Wilson Gut reaction Microscape/Science Photo Library WE HAVE been thinking about Parkinson’s disease all wrong. The condition m...

Deirdre Glenn Head of Life Sciences, Enterprise Ireland LIFE SCIENCES A solid science base of excellent universities and researchers plus multi-nationals makes Ireland the perfect location for life science start-ups to start an export drive. Ireland has a built-in advantage when it comes to exploiting science Regardless of economic ups and downs...

Top Pharma Drugs by Sales in 2017 Top drugs by sales in 2017: Who sold the blockbuster drugs? Published on March 29, 2018 Caroline Polge-Mehta: CoFounder Grow Your Pharma Business Digitally #GenerateBusinessLeads #IncreaseYourDigitalVisibility 25 articles The year 2017 was a landmark year for pharmaceutical industries in the US and Europe, with ...

With the aim of developing a treatment for a rare and debilitating skin disorder, an Irish biopharma company and UCD have signed a gene therapy licensing deal. Amryt, the Irish-listed biopharma company that focuses on rare and so-called ‘orphan’ diseases, has announced the signing of an in-licence agreement with University College Dublin (UCD) t...